Moleculin Biotech, Inc.·4

Nov 6, 8:25 PM ET

PICKER DONALD H 4

4 · Moleculin Biotech, Inc. · Filed Nov 6, 2025

Insider Transaction Report

Form 4
Period: 2025-11-04
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-04+8,75018,902 total
  • Tax Payment

    Common Stock

    2025-11-04$0.50/sh2,131$1,05916,771 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-048,75095,508 total
    Common Stock (8,750 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
  • [F3]On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4